Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 2:41:107897.
doi: 10.1016/j.dib.2022.107897. eCollection 2022 Apr.

Data on urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes

Mikio Marumo  1 , Kazumi Ekawa  1 , Ichiro Wakabayashi  1
Affiliations

Data on urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes

Mikio Marumo et al. Data Brief. .

Abstract

Presented here are the supplemental data of the research article "Urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes" [1]. These data provide the first information on variables that affect urinary levels of pteridines (oxidized-form pteridine derivatives) in patients with diabetes mellitus. In linear regression analysis, gender (women vs. men), current history of smoking and urinary albumin showed significant positive correlations with pteridines, while there were significant inverse correlations of pteridines with a history of alcohol drinking and body mass index. The above associations were confirmed by using analysis of covariance and logistic regression analysis. Among the eight variables (age, gender, medication therapy for diabetes, smoking, alcohol drinking, body mass index, hemoglobin A1c and urinary albumin) tested, smoking showed the strongest association with urinary pteridines.

Keywords: Alcohol; Diabetes; Oxidative stress; Pteridines; Smoking.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests regarding this article.

References

    1. Marumo M., Ekawa K., Wakabayashi I. Urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes. Atheroscler. Plus. 2021;46:27–34. - PMC - PubMed
    1. Wakabayashi I., Nakanishi M., Ohki M., Suehiro A., Uchida K. A simple and useful method for evaluation of oxidative stress in vivo by spectrofluorometric estimation of urinary pteridines. Sci. Rep. 2020;10:11223. - PMC - PubMed
    1. Kashiwagi A., Kasuga M., Araki E., Oka Y., Hanafusa T., Ito H., et al. Committee on the standardization of diabetes mellitus-related laboratory testing of Japan Diabetes Society, International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J. Diabetes Investig. 2012;3:39–40. - PMC - PubMed
    1. , American Diabetes Association 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(Supplement_1):S15–S33. - PubMed

LinkOut - more resources